Mina J. Izadjoo
Research Subjects
Research Interests
Mina J. Izadjoo has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
A. K. Bhattacharjee
1 shared publication- Alexander Stojadinovic
Uniformed Services University of the Health Sciences, Bethesda, MD, USA
1 shared publication - Anthony J. Bauer
Department of Medicine/Gastroenterology, University of Pittsburgh, Pittsburgh, PA
1 shared publication D. L. Hoover
1 shared publication- David G. Binion
Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
1 shared publication David L. Hoover
DHMD Consulting, LLC, 13725 Drake Drive, Rockville, MD 20853, USA
1 shared publication
Latest Publications
- 1 February 2015
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 24 (Sup2) , S10-S14
Antibiofilm efficacy evaluation of a bioelectric dressing in mono- and multi-species biofilms
Objective: Chronic infections are often related to the formation of single or polymicrobial biofilms, which lead to hard-to-treat infections, difficult wound management, and recurrent infections. In this study, we evaluated in vitro antibiofilm properties of a silver and zinc bioelectric dressing (Procellera). Method: We customised and established a poloxamer biofilm model using glass coverslips for the efficacy evaluation of the bioelectric dressing. For antimicrobial susceptibility testing, each bacterial pathogen was diluted to 105CFUs/ml, mixed with 30% poloxamer hydrogels and dropped onto round glass coverslips (25mm diameter) as an abiotic support. Additionally, we mixed four bacterial strains and developed multi-species biofilms in the poloxamer model to examine anti-biofilm efficacy testing against polymicrobial biofilms. Results: After 24 hours incubation, we observed significant inhibition of bacterial growth in nine pathogens (∼2- or 3-fold log10 reduction) compared to controls (no treatment, gauze, and blank polyester with no silver and zinc). The smallest effect was seen with Enterococcus faecalis strain where there was approximately a 1-fold log10 reduction of microbial growth. The antibiofilm efficacy against multi-species (four pathogens) biofilms, evaluated on chromogenic agar plates, was 1- or 2-fold log10 reduction compared to controls. Conclusion: This poloxamer biofilm model was easy to set up, simple to apply, and demonstrated appropriate biofilm formation. The data showed the formation of biofilms inoculated with either single or polymicrobial bacteria under no shear condition, and the bioelectric dressing tested in this study showed effective antibiofilm activity against both the mono- and multi-species biofilms. Declaration of interest: None. The opinions or assertions contained here are the private views of the authors, based on scientific investigation, and are not to be construed as official or as reflecting the views of the US Department of the Army, the Department of Defense, the Department of Veterans Affairs, or the Henry M. Jackson Foundation for the Advancement of Military Medicine.
- 1 February 2015
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 24 (Sup2) , S10-S14
Antibiofilm efficacy evaluation of a bioelectric dressing in mono- and multi-species biofilms
Objective: Chronic infections are often related to the formation of single or polymicrobial biofilms, which lead to hard-to-treat infections, difficult wound management, and recurrent infections. In this study, we evaluated in vitro antibiofilm properties of a silver and zinc bioelectric dressing (Procellera). Method: We customised and established a poloxamer biofilm model using glass coverslips for the efficacy evaluation of the bioelectric dressing. For antimicrobial susceptibility testing, each bacterial pathogen was diluted to 105CFUs/ml, mixed with 30% poloxamer hydrogels and dropped onto round glass coverslips (25mm diameter) as an abiotic support. Additionally, we mixed four bacterial strains and developed multi-species biofilms in the poloxamer model to examine anti-biofilm efficacy testing against polymicrobial biofilms. Results: After 24 hours incubation, we observed significant inhibition of bacterial growth in nine pathogens (∼2- or 3-fold log10 reduction) compared to controls (no treatment, gauze, and blank polyester with no silver and zinc). The smallest effect was seen with Enterococcus faecalis strain where there was approximately a 1-fold log10 reduction of microbial growth. The antibiofilm efficacy against multi-species (four pathogens) biofilms, evaluated on chromogenic agar plates, was 1- or 2-fold log10 reduction compared to controls. Conclusion: This poloxamer biofilm model was easy to set up, simple to apply, and demonstrated appropriate biofilm formation. The data showed the formation of biofilms inoculated with either single or polymicrobial bacteria under no shear condition, and the bioelectric dressing tested in this study showed effective antibiofilm activity against both the mono- and multi-species biofilms. Declaration of interest: None. The opinions or assertions contained here are the private views of the authors, based on scientific investigation, and are not to be construed as official or as reflecting the views of the US Department of the Army, the Department of Defense, the Department of Veterans Affairs, or the Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Open Access
- 28 October 2013
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-7
CD8 Knockout Mice Are Protected from Challenge by Vaccination with WR201, a Live Attenuated Mutant ofBrucella melitensis
CD8+ T cells have been reported to play an important role in defense againstB. abortusinfection in mouse models. In the present report, we use CD8 knockout mice to further elucidate the role of these cells in protection fromB. melitensisinfection. Mice were immunized orally by administration ofB. melitensisWR201, a purine auxotrophic attenuated vaccine strain, then challenged intranasally withB. melitensis16M. In some experiments, persistence of WR201 in the spleens of CD8 knockout mice was slightly longer than that in the spleens of normal mice. However, development of anti-LPS serum antibody, antigen-induced production ofγ-interferon (IFN-γ) by immune splenic lymphocytes, protection against intranasal challenge, and recovery of nonimmunized animals from intranasal challenge were similar between normal and knockout animals. Further, primaryBrucellainfection was not exacerbated in perforin knockout and Fas-deficient mice and these animals’ anti-Brucellaimmune responses were indistinguishable from those of normal mice. These results indicate that CD8+ T cells do not play an essential role as either cytotoxic cells or IFN-γproducers, yet they do participate in a specific immune response to immunization and challenge in this murine model ofB. melitensisinfection.
- 28 October 2013
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-7
Open AccessCD8 Knockout Mice Are Protected from Challenge by Vaccination with WR201, a Live Attenuated Mutant ofBrucella melitensis
CD8+ T cells have been reported to play an important role in defense againstB. abortusinfection in mouse models. In the present report, we use CD8 knockout mice to further elucidate the role of these cells in protection fromB. melitensisinfection. Mice were immunized orally by administration ofB. melitensisWR201, a purine auxotrophic attenuated vaccine strain, then challenged intranasally withB. melitensis16M. In some experiments, persistence of WR201 in the spleens of CD8 knockout mice was slightly longer than that in the spleens of normal mice. However, development of anti-LPS serum antibody, antigen-induced production ofγ-interferon (IFN-γ) by immune splenic lymphocytes, protection against intranasal challenge, and recovery of nonimmunized animals from intranasal challenge were similar between normal and knockout animals. Further, primaryBrucellainfection was not exacerbated in perforin knockout and Fas-deficient mice and these animals’ anti-Brucellaimmune responses were indistinguishable from those of normal mice. These results indicate that CD8+ T cells do not play an essential role as either cytotoxic cells or IFN-γproducers, yet they do participate in a specific immune response to immunization and challenge in this murine model ofB. melitensisinfection.
- Open Access
- 9 May 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (5) , e19867
Production and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System
Burkholderia pseudomallei (BP) and B. mallei (BM) are closely related gram-negative, facultative anaerobic bacteria which cause life-threatening melioidosis in human and glanders in horse, respectively. Our laboratory has previously generated and characterized more than 100 mouse monoclonal antibodies (MAbs) against BP and BM, according to in vitro and in vivo assay. In this study, 3 MAbs (BP7 10B11, BP7 2C6, and BP1 7F7) were selected to develop into chimeric mouse-human monoclonal antibodies (cMAbs) against BP and/or BM. For the stable production of cMAbs, we constructed 4 major different vector systems with a dihydrofolate reductase (DHFR) amplification marker, and optimized transfection/selection conditions in mammalian host cells with the single-gene and/or double-gene expression system. These 3 cMAbs were stably produced by the DHFR double mutant Chinese hamster ovarian (CHO)-DG44 cells. By ELISA and Western blot analysis using whole bacterial antigens treated by heat (65°C/90 min), sodium periodate, and proteinase K, the cMAb BP7 10B11 (cMAb CK1) reacted with glycoproteins (34, 38, 48 kDa in BP; 28, 38, 48 kDa in BM). The cMAb BP7 2C6 (cMAb CK2) recognized surface-capsule antigens with molecular sizes of 38 to 52 kDa, and 200 kDa in BM. The cMAb CK2 was weakly reactive to 14∼28, 200 kDa antigens in BP. The cMAb BP1 7F7 (cMAb CK3) reacted with lipopolysaccharides (38∼52 kDa in BP; 38∼60 kDa in B. thailandensis). Western blot results with the outer surface antigens of the 3 Burkholderia species were consistent with results with the whole Burkholderia cell antigens, suggesting that these immunodominant antigens reacting with the 3 cMAbs were primarily present on the outer surface of the Burkholderia species. These 3 cMAbs would be useful for analyzing the role of the major outer surface antigens in Burkholderia infection.
- 9 May 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (5) , e19867
Open AccessProduction and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System
Burkholderia pseudomallei (BP) and B. mallei (BM) are closely related gram-negative, facultative anaerobic bacteria which cause life-threatening melioidosis in human and glanders in horse, respectively. Our laboratory has previously generated and characterized more than 100 mouse monoclonal antibodies (MAbs) against BP and BM, according to in vitro and in vivo assay. In this study, 3 MAbs (BP7 10B11, BP7 2C6, and BP1 7F7) were selected to develop into chimeric mouse-human monoclonal antibodies (cMAbs) against BP and/or BM. For the stable production of cMAbs, we constructed 4 major different vector systems with a dihydrofolate reductase (DHFR) amplification marker, and optimized transfection/selection conditions in mammalian host cells with the single-gene and/or double-gene expression system. These 3 cMAbs were stably produced by the DHFR double mutant Chinese hamster ovarian (CHO)-DG44 cells. By ELISA and Western blot analysis using whole bacterial antigens treated by heat (65°C/90 min), sodium periodate, and proteinase K, the cMAb BP7 10B11 (cMAb CK1) reacted with glycoproteins (34, 38, 48 kDa in BP; 28, 38, 48 kDa in BM). The cMAb BP7 2C6 (cMAb CK2) recognized surface-capsule antigens with molecular sizes of 38 to 52 kDa, and 200 kDa in BM. The cMAb CK2 was weakly reactive to 14∼28, 200 kDa antigens in BP. The cMAb BP1 7F7 (cMAb CK3) reacted with lipopolysaccharides (38∼52 kDa in BP; 38∼60 kDa in B. thailandensis). Western blot results with the outer surface antigens of the 3 Burkholderia species were consistent with results with the whole Burkholderia cell antigens, suggesting that these immunodominant antigens reacting with the 3 cMAbs were primarily present on the outer surface of the Burkholderia species. These 3 cMAbs would be useful for analyzing the role of the major outer surface antigens in Burkholderia infection.
- Open Access
- 9 February 2011
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 23 (4) , 379-e164
Novel model of peripheral tissue trauma-induced inflammation and gastrointestinal dysmotility
Background Trauma is a leading cause of death and although the gut is recognized as the ‘motor’ of post‐traumatic systemic inflammatory response syndrome and multiple organ failure, studies on the gastrointestinal (GI) tract are few. Our objectives were to create a precisely controllable tissue injury model in which GI motility, systemic inflammation and wound fluid can be analyzed. Methods A non‐narcotic murine trauma model was developed by the subcutaneous dorsal trans‐implantation of a devitalized donor syngeneic harvested tissue–bone matrix (TBX), which was precisely adjusted to % total body weight and studied after 21 h. Gastrointestinal transit histograms were plotted after the oral administration of non‐digestible FITC‐dextran and geometric centers calculated. Organ bath evaluated jejunal circular muscle contractility. Multiplex electrochemiluminescence measurements of serum and TBX wound fluid inflammatory mediators were performed. Key Results Increasing TBX amounts progressively delayed transit, whereas TBX heat denaturation or decellularization prevented ileus and death. In the TBX17.5% model, jejunal muscle contractility was suppressed and a systemic inflammatory response developed as significant serum elevations in IL‐6, keratinocyte cytokine and IL‐10 compared to sham. In addition, inflammatory responses within the wound fluid showed elevated levels of preformed IL‐1β and TNF‐α, whereas, 21 h after implantation IL‐1β, IL‐6 and keratinocyte cytokine were significantly increased in the wound. Conclusions & Inferences A novel donor tissue–bone matrix trauma model was developed that is precisely adjustable and recapitulates important clinical phenomena. The non‐narcotic model demonstrated that increasing tissue injury progressively caused ileus, initiated a systemic inflammatory response and developed inflammatory changes within the wound.
- 9 February 2011
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 23 (4) , 379-e164
Open AccessNovel model of peripheral tissue trauma-induced inflammation and gastrointestinal dysmotility
Background Trauma is a leading cause of death and although the gut is recognized as the ‘motor’ of post‐traumatic systemic inflammatory response syndrome and multiple organ failure, studies on the gastrointestinal (GI) tract are few. Our objectives were to create a precisely controllable tissue injury model in which GI motility, systemic inflammation and wound fluid can be analyzed. Methods A non‐narcotic murine trauma model was developed by the subcutaneous dorsal trans‐implantation of a devitalized donor syngeneic harvested tissue–bone matrix (TBX), which was precisely adjusted to % total body weight and studied after 21 h. Gastrointestinal transit histograms were plotted after the oral administration of non‐digestible FITC‐dextran and geometric centers calculated. Organ bath evaluated jejunal circular muscle contractility. Multiplex electrochemiluminescence measurements of serum and TBX wound fluid inflammatory mediators were performed. Key Results Increasing TBX amounts progressively delayed transit, whereas TBX heat denaturation or decellularization prevented ileus and death. In the TBX17.5% model, jejunal muscle contractility was suppressed and a systemic inflammatory response developed as significant serum elevations in IL‐6, keratinocyte cytokine and IL‐10 compared to sham. In addition, inflammatory responses within the wound fluid showed elevated levels of preformed IL‐1β and TNF‐α, whereas, 21 h after implantation IL‐1β, IL‐6 and keratinocyte cytokine were significantly increased in the wound. Conclusions & Inferences A novel donor tissue–bone matrix trauma model was developed that is precisely adjustable and recapitulates important clinical phenomena. The non‐narcotic model demonstrated that increasing tissue injury progressively caused ileus, initiated a systemic inflammatory response and developed inflammatory changes within the wound.
- 1 May 2008
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 55 (3-4) , 145-151
A Study on the Use of Male Animal Models for Developing a Live Vaccine for Brucellosis
To study the safety of Brucella melitensis WR201, a live vaccine candidate, we compared the course of infection of this strain with that of virulent 16M in male BALB/c mice. At various times after oral immunization with strains WR201 or 16M, lungs, liver, spleen, testis, epididymis, inguinal and cervical lymph nodes were removed. Tissues were divided for microbiologic culture and histopathological examination. WR201 infection in male BALB/c mice had lower intensity and shorter duration than infection caused by virulent 16M. Pathological examination of testis and epididymis revealed no inflammation following strain WR201 immunization. In contrast, animals given virulent 16M strain had substantial inflammation in infected tissues. These data confirm the marked attenuation of WR201 relative to 16M. In addition, these studies suggest that male mice may be useful to assess the safety of live, attenuated Brucella vaccine candidates.
- 1 May 2008
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 55 (3-4) , 145-151
A Study on the Use of Male Animal Models for Developing a Live Vaccine for Brucellosis
To study the safety of Brucella melitensis WR201, a live vaccine candidate, we compared the course of infection of this strain with that of virulent 16M in male BALB/c mice. At various times after oral immunization with strains WR201 or 16M, lungs, liver, spleen, testis, epididymis, inguinal and cervical lymph nodes were removed. Tissues were divided for microbiologic culture and histopathological examination. WR201 infection in male BALB/c mice had lower intensity and shorter duration than infection caused by virulent 16M. Pathological examination of testis and epididymis revealed no inflammation following strain WR201 immunization. In contrast, animals given virulent 16M strain had substantial inflammation in infected tissues. These data confirm the marked attenuation of WR201 relative to 16M. In addition, these studies suggest that male mice may be useful to assess the safety of live, attenuated Brucella vaccine candidates.